Raymond James Financial Services Advisors, Inc. Teva Pharmaceutical Industries LTD Transaction History

Raymond James Financial Services Advisors, Inc.

  • $69.1 Billion
  • Q2 2024

A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 64,703 shares of TEVA stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,703
Previous 65,116 0.63%
Holding current value
$1.16 Million
Previous $918,000 14.49%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024
SELL
$12.78 - $17.4 $5,278 - $7,186
-413 Reduced 0.63%
64,703 $1.05 Million
Q1 2024

Apr 22, 2024
SELL
$10.67 - $14.43 $83,332 - $112,698
-7,810 Reduced 10.71%
65,116 $918,000
Q4 2023

Jan 16, 2024
SELL
$8.12 - $10.63 $6,390 - $8,365
-787 Reduced 1.07%
72,926 $761,000
Q3 2023

Oct 24, 2023
SELL
$7.48 - $10.7 $5,804 - $8,303
-776 Reduced 1.04%
73,713 $751,000
Q2 2023

Jul 25, 2023
SELL
$7.2 - $9.47 $135,180 - $177,799
-18,775 Reduced 20.13%
74,489 $560,000
Q1 2023

Apr 14, 2023
SELL
$8.36 - $11.37 $47,351 - $64,399
-5,664 Reduced 5.73%
93,264 $825,000
Q4 2022

Feb 08, 2023
SELL
$7.95 - $9.48 $11,654 - $13,897
-1,466 Reduced 1.46%
98,928 $902,000
Q3 2022

Oct 25, 2022
SELL
$6.86 - $11.95 $175,609 - $305,908
-25,599 Reduced 20.32%
100,394 $810,000
Q2 2022

Aug 12, 2022
BUY
$7.38 - $10.4 $72,752 - $102,523
9,858 Added 8.49%
125,993 $947,000
Q1 2022

May 11, 2022
BUY
$7.33 - $9.39 $61,058 - $78,218
8,330 Added 7.73%
116,135 $1.09 Million
Q4 2021

Feb 08, 2022
SELL
$7.9 - $10.19 $347,244 - $447,901
-43,955 Reduced 28.96%
107,805 $864,000
Q3 2021

Nov 02, 2021
SELL
$8.38 - $10.18 $1.27 Million - $1.55 Million
-152,111 Reduced 50.06%
151,760 $1.48 Million
Q2 2021

Aug 11, 2021
SELL
$9.9 - $11.56 $2.87 Million - $3.36 Million
-290,358 Reduced 48.86%
303,871 $3.01 Million
Q1 2021

May 14, 2021
BUY
$10.34 - $12.81 $270,845 - $335,545
26,194 Added 4.61%
594,229 $6.86 Million
Q4 2020

Feb 12, 2021
BUY
$8.61 - $11.04 $136,253 - $174,708
15,825 Added 2.87%
568,035 $5.48 Million
Q3 2020

Nov 04, 2020
BUY
$8.57 - $12.69 $538,041 - $796,703
62,782 Added 12.83%
552,210 $4.98 Million
Q2 2020

Jul 17, 2020
BUY
$8.12 - $13.12 $205,265 - $331,660
25,279 Added 5.45%
489,428 $6.04 Million
Q1 2020

Apr 21, 2020
BUY
$6.69 - $13.45 $695,010 - $1.4 Million
103,888 Added 28.84%
464,149 $4.17 Million
Q4 2019

Feb 12, 2020
BUY
$6.53 - $10.72 $828,239 - $1.36 Million
126,836 Added 54.34%
360,261 $3.53 Million
Q3 2019

Nov 07, 2019
SELL
$6.16 - $9.6 $52,544 - $81,888
-8,530 Reduced 3.53%
233,425 $1.61 Million
Q2 2019

Aug 06, 2019
BUY
$8.12 - $15.72 $1.48 Million - $2.87 Million
182,523 Added 307.11%
241,955 $2.23 Million
Q1 2019

May 06, 2019
SELL
$15.58 - $20.01 $261,042 - $335,267
-16,755 Reduced 21.99%
59,432 $932,000
Q4 2018

Feb 11, 2019
BUY
$14.59 - $23.84 $21,841 - $35,688
1,497 Added 2.0%
76,187 $1.18 Million
Q3 2018

Nov 14, 2018
SELL
$21.06 - $25.65 $184,969 - $225,283
-8,783 Reduced 10.52%
74,690 $1.61 Million
Q2 2018

Jul 30, 2018
BUY
$16.77 - $24.71 $284,184 - $418,735
16,946 Added 25.47%
83,473 $2.03 Million
Q1 2018

Apr 16, 2018
SELL
$16.68 - $22.07 $33,877 - $44,824
-2,031 Reduced 2.96%
66,527 $1.14 Million
Q4 2017

Feb 09, 2018
SELL
$11.23 - $19.1 $84,449 - $143,632
-7,520 Reduced 9.88%
68,558 $1.3 Million
Q3 2017

Oct 26, 2017
SELL
$15.41 - $32.17 $1.29 Million - $2.69 Million
-83,555 Reduced 52.34%
76,078 $1.34 Million
Q2 2017

Aug 15, 2017
BUY
N/A
159,633
159,633 $5.3 Million

Others Institutions Holding TEVA

# of Institutions
603
Shares Held
567M
Call Options Held
25.2M
Put Options Held
5.08M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email